A brief pointer to information on nausea, a common side effect of GLP-1 drugs. The post itself offers no further detail.
Recap by typeshit. Post by Facebook on Facebook.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
Online sellers pitch peptides for weight loss, anti-aging and muscle gain, and Gavin Coote's full story looks at the risks of products nobody regulates.
Several studies at the 2026 ASCO Annual Meeting examined how GLP-1 medications and weight loss relate to breast cancer risk. These are associations, not proof of cause.
The talk promises to go past the scale and headlines to focus on overall health and wellbeing for people on GLP-1 drugs.
Loading…